MARKET HARBOROUGH MED.CTR — All Prescriptions & Medications — Page 6
Practice Code: C82009 | MARKET HARBOROUGH, LE16 9BX
Showing results 251-300 of 866
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Powder extensively hydrolysed formula (0913101) | 310 | 872.4K | £25.7K | +330.3% ▲ |
| Alogliptin | 309 | 6,552 | £5.9K | +21.8% ▲ |
| Ready to serve 1.5 kcal/ml juice style (0913011) | 309 | 1.9M | £16.6K | +408.3% ▲ |
| Urea | 307 | 143.8K | £4.3K | +359.5% ▲ |
| Hydrocortisone | 305 | 8,134 | £1.9K | +301.6% ▲ |
| Docusate sodium | 304 | 45.6K | £3.1K | -18.0% ▼ |
| Lisdexamfetamine dimesylate | 304 | 8,883 | £21.4K | +154.6% ▲ |
| Metoclopramide hydrochloride | 304 | 15.2K | £531 | +266.9% ▲ |
| Biphasic isophane insulin | 304 | 2,370 | £10.2K | +172.5% ▲ |
| Anastrozole | 302 | 7,392 | £355 | +231.7% ▲ |
| 301 | 32.8K | £1.6K | +331.4% ▲ | |
| Fenofibrate | 298 | 6,290 | £759 | +208.0% ▲ |
| Tamsulosin and dutasteride hydrochloride | 298 | 8,848 | £2.9K | +752.6% ▲ |
| Adrenaline | 296 | 626 | £36.5K | +369.4% ▲ |
| RtS 1.4 - 2 kcal/g dessert style (milk based) (0913011) | 289 | 982.5K | £17.3K | +657.3% ▲ |
| 285 | 23.3K | £2.0K | +31.8% ▲ | |
| Dihydrocodeine tartrate | 284 | 25.9K | £1.6K | +45.4% ▲ |
| Aclidinium bromide | 281 | 281 | £8.6K | +958.9% ▲ |
| Clotrimazole | 280 | 3,089 | £2.7K | +153.8% ▲ |
| Vortioxetine | 274 | 6,454 | £6.0K | +294.8% ▲ |
| Medroxyprogesterone acetate | 272 | 278 | £1.5K | +125.3% ▲ |
| Mometasone furoate | 272 | 18.0K | £1.7K | +103.4% ▲ |
| 269 | 47.4K | £2.9K | +164.8% ▲ | |
| Tranexamic acid | 265 | 16.6K | £1.1K | +212.6% ▲ |
| Triamcinolone acetonide | 263 | 268 | £355 | +251.6% ▲ |
| 263 | 6,148 | £2.0K | +688.0% ▲ | |
| Ketoconazole | 262 | 35.0K | £6.1K | +166.8% ▲ |
| 262 | 145.2K | £1.9K | +187.3% ▲ | |
| Rabeprazole sodium | 259 | 7,525 | £657 | +402.2% ▲ |
| Adapalene and benzoyl peroxide | 258 | 12.6K | £5.5K | +383.1% ▲ |
| Irbesartan | 257 | 6,478 | £279 | +5.5% ▲ |
| Terbinafine hydrochloride | 250 | 8,686 | £3.5K | +304.5% ▲ |
| RtS 2.4 kcal/ml m/sk lower volume, higher protein (0913011) | 250 | 1.1M | £22.1K | +257.2% ▲ |
| Other individually formulated bought in preparations | 249 | 14.6K | £13.0K | +662.1% ▲ |
| Amisulpride | 247 | 5,964 | £2.6K | +251.4% ▲ |
| Rasagiline mesilate | 246 | 5,542 | £5.1K | +562.3% ▲ |
| 246 | 6,960 | £1.5K | +470.6% ▲ | |
| Fluticasone/umeclidinium/vilanterol | 245 | 247 | £10.4K | +4.5% ▲ |
| Colchicine | 245 | 7,634 | £158 | +214.1% ▲ |
| Glycopyrronium bromide | 245 | 1,740 | £2.8K | +928.2% ▲ |
| Oxytetracycline | 243 | 22.9K | £8.4K | +840.8% ▲ |
| Insulin Lispro | 241 | 1,553 | £13.0K | +215.0% ▲ |
| Duloxetine hydrochloride | 239 | 7,448 | £1.7K | +366.4% ▲ |
| Procyclidine hydrochloride | 237 | 8,673 | £396 | +67.5% ▲ |
| Telmisartan | 236 | 7,336 | £1.7K | +307.1% ▲ |
| Dulaglutide | 236 | 952 | £16.9K | +105.9% ▲ |
| Midazolam hydrochloride | 236 | 2,438 | £1.4K | +476.6% ▲ |
| 234 | 20.9K | £39.3K | +380.1% ▲ | |
| Combined ethinylestradiol 20mcg | 231 | 12.5K | £2.5K | +342.2% ▲ |
| Orlistat | 230 | 16.1K | £3.9K | +179.0% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.